• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Apremilast for a psoriasis patient with HIV and hepatitis C.

作者信息

Reddy S P, Shah V V, Wu J J

机构信息

University of Illinois at Chicago College of Medicine, Chicago, IL, USA.

University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.

出版信息

J Eur Acad Dermatol Venereol. 2017 Nov;31(11):e481-e482. doi: 10.1111/jdv.14301. Epub 2017 May 15.

DOI:10.1111/jdv.14301
PMID:28449227
Abstract
摘要

相似文献

1
Apremilast for a psoriasis patient with HIV and hepatitis C.阿普斯特用于一名合并感染艾滋病毒和丙型肝炎的银屑病患者。
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):e481-e482. doi: 10.1111/jdv.14301. Epub 2017 May 15.
2
Apremilast as therapeutic option in a HIV positive patient with severe psoriasis.阿普司特作为一名重度银屑病HIV阳性患者的治疗选择。
Dermatol Ther. 2018 Nov;31(6):e12719. doi: 10.1111/dth.12719. Epub 2018 Oct 24.
3
Apremilast and phototherapy for treatment of psoriasis in a patient with human immunodeficiency virus.阿普司特与光疗用于治疗一名人类免疫缺陷病毒患者的银屑病
Cutis. 2019 May;103(5):E6-E7.
4
A case of anti-laminin γ1 (p200) pemphigoid with psoriasis vulgaris successfully treated with apremilast.一例伴有寻常型银屑病的抗层粘连蛋白γ1（p200）类天疱疮患者经阿普米拉斯成功治疗。
Eur J Dermatol. 2018 Jun 1;28(3):413-414. doi: 10.1684/ejd.2018.3280.
5
Psoriasis and chronic myeloid leukemia: treatment with Apremilast.银屑病与慢性髓性白血病：阿普司特治疗
Int J Dermatol. 2020 Apr;59(4):e102-e103. doi: 10.1111/ijd.14598. Epub 2019 Jul 26.
6
Apremilast efficacy and safety in a psoriatic arthritis patient affected by HIV and HBV virus infections.阿普米司特治疗感染 HIV 和 HBV 病毒的银屑病关节炎患者的疗效和安全性。
Postgrad Med. 2019 Apr;131(3):239-240. doi: 10.1080/00325481.2019.1575613. Epub 2019 Feb 8.
7
Apremilast, beyond psoriasis as a therapeutic target.阿普司特，作为一种治疗靶点，其作用超出了银屑病范畴。
Med Clin (Barc). 2017 Jul 7;149(1):42-43. doi: 10.1016/j.medcli.2017.01.008. Epub 2017 Feb 24.
8
Rapid improvement of nail matrix psoriasis with apremilast: clinical and ultrasonographic assessment.阿普司特治疗甲母质银屑病的快速改善：临床及超声评估
Clin Exp Dermatol. 2018 Jul;43(5):606-607. doi: 10.1111/ced.13411. Epub 2018 Feb 16.
9
Apremilast in a patient with psoriasis and mantle cell lymphoma under maintenance treatment with rituximab.在用利妥昔单抗维持治疗的银屑病和套细胞淋巴瘤患者中使用阿普米拉斯。
J Dtsch Dermatol Ges. 2019 Mar;17(3):330-332. doi: 10.1111/ddg.13771. Epub 2019 Feb 18.
10
Synergistic cytokine effects as apremilast response predictors in patients with psoriasis.银屑病患者中协同细胞因子效应作为阿普斯特反应预测指标
J Allergy Clin Immunol. 2018 Sep;142(3):1010-1013.e6. doi: 10.1016/j.jaci.2018.05.039. Epub 2018 Jun 21.

引用本文的文献

1
Apremilast in Psoriasis Patients With Serious Comorbidities: a Case Series and Systematic Review of Literature.阿普司特治疗伴有严重合并症的银屑病患者：病例系列及文献系统评价
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022179. doi: 10.5826/dpc.1204a179. eCollection 2022 Nov.
2
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease.银屑病的新型治疗方法与传染病风险
Biomedicines. 2022 Jan 21;10(2):228. doi: 10.3390/biomedicines10020228.
3
The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios.
阿普米拉斯在银屑病治疗中的应用：印度对现实世界情况的看法。
Psoriasis (Auckl). 2021 Aug 14;11:109-122. doi: 10.2147/PTT.S320810. eCollection 2021.
4
Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2).银屑病合并炎症性、神经性、感染性或恶性疾病时全身治疗的实用建议（BETA-PSO：比利时银屑病循证治疗建议；第2部分）
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1914-1923. doi: 10.1111/jdv.16683. Epub 2020 Aug 13.
5
Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients.致编辑的信：磷酸二酯酶4抑制剂对新冠病毒肺炎患者的免疫调节作用
Metabolism. 2020 Sep;110:154300. doi: 10.1016/j.metabol.2020.154300. Epub 2020 Jun 20.
6
COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.患有少突胶质细胞瘤的红皮病型银屑病患者的COVID-19肺部感染：阿普米司特与重症监护管理的安全性和兼容性
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e376-e378. doi: 10.1111/jdv.16625. Epub 2020 Jun 4.
7
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence.司库奇尤单抗在复杂患者情况中治疗银屑病：现有证据综述
Dermatol Ther (Heidelb). 2020 Jun;10(3):351-364. doi: 10.1007/s13555-020-00373-z. Epub 2020 Apr 2.
8
Apremilast in People Living with HIV with Psoriasis Vulgaris: A Case Report.阿普司特治疗寻常型银屑病合并HIV感染者：一例报告
Indian J Dermatol. 2019 May-Jun;64(3):242-244. doi: 10.4103/ijd.IJD_633_18.
9
Treatment of moderate to severe psoriasis with apremilast over 2 years in the context of long-term treated HIV infection: A case report.在长期接受治疗的HIV感染背景下，使用阿普米拉斯治疗中度至重度银屑病2年：一例病例报告。
SAGE Open Med Case Rep. 2019 May 6;7:2050313X19845193. doi: 10.1177/2050313X19845193. eCollection 2019.
10
HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.抗逆转录病毒治疗时代的 HIV 相关皮肤疾病：识别与管理。
Am J Clin Dermatol. 2019 Jun;20(3):423-442. doi: 10.1007/s40257-019-00422-0.